SCHEMBL2196367

SCHEMBL2196367

Cc1cc(F)ccc1Nc1ccc(C(=O)c2cc(O)ccc2C)c([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 3/20 0.53
MAPK12 P53778 3/20 0.53
MAPK11 Q15759 3/20 0.53
MAPK14 Q16539 3/20 0.53
ALDH1A1 P00352 7/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
LMNA P02545 3/20 0.43
ATM Q13315 1/20 0.43
ALDH3A1 P30838 2/20 0.42
MAPT P10636 7/20 0.41
MAPK1 P28482 4/20 0.41
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
TDP1 Q9NUW8 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PKM P14618 2/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KCNMA1 Q12791 1/20 0.39
IDH1 O75874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2574991 0.93 MAPK14 (0.45) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2198034 0.83 MAPK14 (0.46) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2199243 0.83 ALDH1A1 (0.45) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2199456 0.81 MAPK14 (0.47) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2859207 0.78 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2201701 0.77 MAPK14 (0.57) MAPK14ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL2198632 0.77 MAPK14 (0.53) MAPK13MAPK12MAPK11MAPK14
SCHEMBL2196584 0.77 MAPK14 (0.52) MAPK13MAPK12MAPK11MAPK14ALDH3A1
SCHEMBL2200104 0.76 ALDH1A1 (0.44) MAPK14ALDH1A1SMN1; SMN2MAPTMAPK1
SCHEMBL2198903 0.75 MAPK14 (0.71) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
CN-1826310-B Novel aminobenzophenone compounds LEO PHARMA AS 2010-07-21 CN disclosed
CN-1826310-A Novel aminobenzophenone compounds LEO PHARMA AS (DK) 2006-08-30 CN disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.